Chronic Anemia Clinical Trial
Official title:
The Effect of Chronic Anemia on Safety Period of Tracheal Intubation in Gynecology Patients
1. Every individual receiving a general anesthetic is at potential risk for developing a
''cannot intubate-cannot ventilate'' situation following anesthetic induction.
2. Building up of oxygen reserves assumes great significance as this provides a longer
duration of non-hypoxic apnea should one be faced with an unanticipated difficult
airway.
3. The main physiological functions of red blood cell hemoglobin are to deliver oxygen to
the peripheral tissues.
4. During anemia, a reduction in blood oxygen content occurs as a result of reduced Hb
while arterial oxygenation and oxyhemoglobin saturation remain high.
5. Previous studies about the duration of non-hypoxic apnoea focus on methods to improve
the safety period of tracheal intubation.
6. To our knowledge, there is no literature about the duration of non-hypoxic apnoea of
anemia patients.
7. The aim of this study was to assess the effect of chronic anemia on the duration of
non-hypoxic apnoea during induction of anaesthesia.
Status | Completed |
Enrollment | 45 |
Est. completion date | September 2013 |
Est. primary completion date | September 2013 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: 1. patients scheduled to undergo general anesthesia 2. American Society of Anesthesiologists Performance Status 1-2 3. adults Exclusion Criteria: 1. Individuals with significant cardiorespiratory or cerebrovascular disease, 2. difficult intubation 3. history of epilepsy 4. body mass index >25 kg/m2, 5. and those who had smoking history in past 6 months |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
China | Fudan university | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Fudan University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | duration of non-hypoxic apnoea | up to 6 months | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00631163 -
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
|
Phase 2 | |
Completed |
NCT03802201 -
Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia
|
Phase 2 |